KZA
Click for more information
0.00% 8.0¢ kazia therapeutics limited

Ann: Kazia's paxalisib granted Fast Track Designation by FDA, page-4

  1. Firesale
    1,730 Posts.
    lightbulb Created with Sketch. 96
    clock Created with Sketch.
    20/08/20
    09:00
    Post #: 46675872
    FTD also allows for ‘rolling review’, whereby Kazia may submit completed sections of the paxalisib NDA as they become available, rather than at the end of development • Kazia consequently plans to begin initial preparatory activities for NDA filing for paxalisib in CY2021

    Awesome smile.png
    KZA Price at posting: 82.5¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 10  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

M2R Miramar sniffs 5.48% Cu, 54.4% Pb and 73.48g/t Ag at new WA prospect
right-arrow Created with Sketch.
AMI First stope ore could be pushed back to Q2 FY25 due to flood-like event: Aurelia
right-arrow Created with Sketch.
SKC SkyCity to lose NZ$5M in 2025 over complaint closedown
right-arrow Created with Sketch.
AGY Argosy signs deal to sell battery-grade Rincon lithium to Korea
right-arrow Created with Sketch.
FMG Andrew Forrest was seemingly possessed by the spirit of hydrogen – now he's cut 700 jobs and canned FFI
right-arrow Created with Sketch.
WGX Australian foreign investment regulators greenlight Westgold's buyout of Karora
right-arrow Created with Sketch.
watchlist Created with Sketch. Add KZA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.